News
AstraZeneca and HSCI partner to develop new medicines for...
AstraZeneca has established a five-year research collaboration with Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells....
News
GSK and CSHL to develop new treatment for obesity...
The partnership will identify potent, selective and orally bioavailable small molecules that inhibit PTP1B activity in-vivo following stimulation by insulin and leptin to overcome resistance...
News
Takeda and ImmunoGen partner to develop anti-cancer therapeutics
Japanese drug maker Takeda Pharmaceutical Company, through its wholly owned subsidiary Millennium Pharmaceuticals, has signed an agreement with US-based ImmunoGen to develop and commercialise anti-cancer...
News
Dilaforette’s sevuparin obtains FDA orphan drug designation to treat...
Swedish firm Dilaforette has received orphan drug designation from the US Food and Drug Administration (FDA) for its sevuparin (DF02) to treat patients with sickle-cell...
News
China’s Innovent and Eli Lilly partner to develop three...
US-based Eli Lilly and Company has partnered with Chinese drug development firm Innovent Biologics to develop and commercialise three cancer treatments over the next decade....
News
Evotec signs five-year multi-component agreement with Sanofi
Germany-based Evotec has signed an agreement with French drugmaker Sanofi for a major multi-component strategic partnership over the next five years. As...
News
Eli Lilly and Hanmi to develop BTK inhibitor to...
US-based Eli Lilly and Company has signed an exclusive licence and collaboration agreement with Hanmi Pharmaceutical to develop and commercialise an immunological therapy. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.